Insulin Glargine + Lixisenatide
Composition
This Formulation cotains Insulin Glargine and Lixisenatide as active pharmaceutical ingrediant.
Indications
Used for the treatment of type 2 diabetes mellitus
Side effects
Common side effects include hypoglycemia, gastrointestinal effects, headache.
Precautions
Use with caution in patients with a history of pancreatitis, renal impairment, or thyroid disorders.
Contraindications
Contraindicated in patients with medullary thyroid carcinoma
Dosage and administration
Administered once daily via subcutaneous injection
Countries
Worldwide
Available Forms
prefilled syringes for subcutaneous
Manufacturing Services
Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai